Literature DB >> 12869201

Identification of different isoforms of eEF1A in the nuclear fraction of human T-lymphoblastic cancer cell line specifically binding to aptameric cytotoxic GT oligomers.

Barbara Dapas1, Gianluca Tell, Andrea Scaloni, Alex Pines, Lino Ferrara, Franco Quadrifoglio, Bruna Scaggiante.   

Abstract

GT oligomers, showing a dose-dependent cytotoxic effect on a variety of human cancer cell lines, but not on normal human lymphocytes, recognize and form complexes with nuclear proteins. By working with human T-lymphoblastic CCRF-CEM cells and by using MS and SouthWestern blotting, we identified eukaryotic elongation factor 1 alpha (eEF1A) as the main nuclear protein that specifically recognizes these oligonucleotides. Western blotting and supershift assays confirmed the nature of this protein and its involvement in forming a cytotoxicity-related complex (CRC). On the contrary, normal human lymphocytes did not show nuclear proteins able to produce CRC in a SouthWestern blot. Comparative bidimensional PAGE and Western-blotting analysis for eEF1A revealed the presence of a specific cluster of spots, focusing at more basic pH, in nuclear extracts of cancer cells but absent in those of normal lymphocytes. Moreover, a bidimensional PAGE SouthWestern blot demonstrated that cytotoxic GT oligomers selectively recognized the more basic eEF1A isoform expressed only in cancer cells. These results suggest the involvement of eEF1A, associated with the nuclear-enriched fraction, in the growth and maintenance of tumour cells, possibly modulated by post-translational processing of the polypeptide chain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12869201     DOI: 10.1046/j.1432-1033.2003.03713.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

Review 1.  Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.

Authors:  Paula J Bates; Damian A Laber; Donald M Miller; Shelia D Thomas; John O Trent
Journal:  Exp Mol Pathol       Date:  2009-01-20       Impact factor: 3.362

2.  LC/LC-MS/MS of an innovative prostate human epithelial cancer (PHEC) in vitro model system.

Authors:  John D Lapek; James L McGrath; William A Ricke; Alan E Friedman
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-03-03       Impact factor: 3.205

3.  DNA aptamers to human immunodeficiency virus reverse transcriptase selected by a primer-free SELEX method: characterization and comparison with other aptamers.

Authors:  Yi-Tak Lai; Jeffrey J DeStefano
Journal:  Nucleic Acid Ther       Date:  2012-05-03       Impact factor: 5.486

Review 4.  Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials.

Authors:  Bruna Scaggiante; Maryam Kazemi; Gabriele Pozzato; Barbara Dapas; Rosella Farra; Mario Grassi; Fabrizio Zanconati; Gabriele Grassi
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

5.  Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity.

Authors:  Tamara M Leclercq; Paul A B Moretti; Mathew A Vadas; Stuart M Pitson
Journal:  J Biol Chem       Date:  2008-02-08       Impact factor: 5.157

6.  A promoter SNP rs4073T>A in the common allele of the interleukin 8 gene is associated with the development of idiopathic pulmonary fibrosis via the IL-8 protein enhancing mode.

Authors:  Mi-Hyun Ahn; Byung-Lae Park; Shin-Hwa Lee; Sung-Woo Park; Jong-Sook Park; Do-Jin Kim; An-Soo Jang; Jai-Soung Park; Hwa-Kyun Shin; Soo-Taek Uh; Yang-Ki Kim; Young Whan Kim; Sung Koo Han; Ki-Suck Jung; Kye Young Lee; Sung Hwan Jeong; Jeong Woong Park; Byoung Whui Choi; In Won Park; Man Pyo Chung; Hyoung Doo Shin; Jin Woo Song; Dong Soon Kim; Choon-Sik Park; Young-Soo Shim
Journal:  Respir Res       Date:  2011-06-08

7.  Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression.

Authors:  B Scaggiante; B Dapas; S Bonin; M Grassi; C Zennaro; R Farra; L Cristiano; S Siracusano; F Zanconati; C Giansante; G Grassi
Journal:  Br J Cancer       Date:  2011-11-17       Impact factor: 7.640

8.  Cytotoxic G-rich oligodeoxynucleotides: putative protein targets and required sequence motif.

Authors:  Amber Goodchild; Andrew King; Mary Margaret Gozar; Toby Passioura; Carly Tucker; Laurent Rivory
Journal:  Nucleic Acids Res       Date:  2007-06-22       Impact factor: 16.971

9.  An eEF1A1 truncation encoded by PTI-1 exerts its oncogenic effect inside the nucleus.

Authors:  Louise D Dahl; Thomas J Corydon; Liina Ränkel; Karen Margrethe Nielsen; Ernst-Martin Füchtbauer; Charlotte R Knudsen
Journal:  Cancer Cell Int       Date:  2014-02-26       Impact factor: 5.722

Review 10.  Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases.

Authors:  Valentina Giudice; Francesca Mensitieri; Viviana Izzo; Amelia Filippelli; Carmine Selleri
Journal:  Int J Mol Sci       Date:  2020-05-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.